Largest biotech by total assets

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech ranked by total assets, at CHF 76.2B, ahead of Gilead Sciences (CHF 49.7B) and Biogen (CHF 24.8B). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenCHF 76.2B
Median
CHF 2.2B
Combined market value
CHF 712.2B
Countries
5

Market values as of .

Largest biotech by total assets
#CompanyTotal assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareCHF 76.2BCHF 205.9BCHF 380.62 1.25% down 34% up United States
2Gilead SciencesGILD · Health CareCHF 49.7BCHF 176.8BCHF 142.50 0.56% down 33% up United States
3BiogenBIIB · Health CareCHF 24.8BCHF 31.3BCHF 211.62 0.25% up 49% up United States
4BioNTechBNTX · Health CareCHF 20.5BCHF 17.7BCHF 71.44 0.02% up 16% down Germany
5ModernaMRNA · Health CareCHF 10.4BCHF 70.2BCHF 173.41 0.38% down 755% up United States
6argenxARGX · Health CareCHF 7.3BCHF 50.7BCHF 806.69 1.15% up 4% up Belgium
7QiagenQGEN · Health CareCHF 5.3BCHF 8.6BCHF 41.84 0.07% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareCHF 3.9BCHF 14.1BCHF 139.42 0.17% down 20% up United States
9VaxcytePCVX · Health CareCHF 2.5BCHF 7.9BCHF 49.85 0.29% down 22% up United States
10RepligenRGEN · Health CareCHF 2.5BCHF 9.1BCHF 142.28 4.23% up 5% up United States
11ExelixisEXEL · Health CareCHF 2.4BCHF 14.1BCHF 57.94 0.49% up 63% up United States
12Bio-TechneTECH · Health CareCHF 2.2BCHF 9.6BCHF 61.21 0.12% up 26% up United States
13Halozyme TherapeuticsHALO · Health CareCHF 2.1BCHF 9.2BCHF 80.78 0.01% up 37% up United States
14Revolution MedicinesRVMD · Health CareCHF 2BCHF 29.4BCHF 136.11 0.60% down 131% up United States
15CRISPR TherapeuticsCRSP · Health CareCHF 1.9BCHF 3.4BCHF 35.40 4.74% up 21% down Switzerland
16Kymera TherapeuticsKYMR · Health CareCHF 1.5BCHF 8.8BCHF 102.83 0.53% up 87% up United States
17Krystal BiotechKRYS · Health CareCHF 1.1BCHF 7.5BCHF 254.26 1.18% up 46% up United States
18ImmunovantIMVT · Health CareCHF 805.5MCHF 5.8BCHF 28.25 1.05% up 43% up United States
19CG OncologyCGON · Health CareCHF 666.3MCHF 6BCHF 67.10 0.98% up 85% up United States
20Twist BioscienceTWST · Health CareCHF 540.3MCHF 6.4BCHF 93.25 1.08% down 340% up United States
21Adaptive BiotechnologiesADPT · Health CareCHF 431.6MCHF 3.9BCHF 24.06 0.32% up 88% up United States
22ImmunityBioIBRX · Health CareCHF 422.5MCHF 5.6BCHF 5.22 0.93% down 193% up United States
23Scholar Rock HoldingSRRK · Health CareCHF 340.3MCHF 4.8BCHF 39.61 4.40% up 14% up United States
24Kodiak SciencesKOD · Health CareCHF 295.9MCHF 5.4BCHF 81.97 0.60% up 396% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8417 CHF).

Questions and answers

Which biotech rank first by total assets?

Amgen (CHF 76.2B), Gilead Sciences (CHF 49.7B) and Biogen (CHF 24.8B) are the top three of the 24 biotech ranked by total assets as of 18 Nov 2026, 14:39 UTC.

How many biotech are in this ranking?

24 are ranked by total assets.

What are these biotech worth together?

The 24 biotech ranked by total assets have a combined market value of CHF 712.2B as of 18 Nov 2026, 14:39 UTC.

What does ranking by total assets measure?

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets

Underlying data: Yahoo Finance; SEC EDGAR.